Treace Medical price target lowered to $9.50 from $10 at Truist
Truist lowered the firm’s price target on Treace Medical (TMCI) to $9.50 from $10 and keeps a Hold rating on the shares after its recent ...
Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Treace Medical Concepts (TMCI – Research ...